IMO, it seems to me if this process were to have been a major money maker it would have stood a much better chance prior to the recent EO. Adult Stem Cell claims, recent EO allowing destruction all seem to take away from importance rather than adding to it. I would assume if patent procedure were approved ACTC would have companies interested.
If in fact this procedure was something all stem companies had to have or wanted to have, big Pharmas, the scientific community and big investors would have been placing their dollars with ACTC...that is not the case.